Veterinary Anesthetic Alfaxan Approved for U.S. Distribution

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs.


Published:

Each milliliter of Alfaxan contains 10 milligrams of the active ingredient alfaxalone.

An intravenous injectable anesthetic commonly used in Australia will be released to U.S. veterinarians Aug. 25, the manufacturer, Jurox Animal Health, reported.

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs. The drug is indicated for the induction and maintenance of anesthesia and for the induction of anesthesia followed by maintenance with an inhalant anesthetic.

Winning U.S. Food and Drug Administration approval of Alfaxan took time, said JJ O’Brien, CEO of Australia-based Jurox.

“Since beginning this process, we have had countless inquiries as to why it has not been available to U.S. veterinarians,” O’Brien said.

The drug is widely accepted by Australian veterinarians and has been used in 20 countries.

“An independent study commissioned by Jurox reported Australian veterinarians to rely on Alfaxan for induction as often as 74 percent of the time in cats and 52 percent in dogs,” the company stated.

Alfaxan’s U.S. distributors will include Henry Schein Animal Health, MWI Veterinary Supply, Patterson Veterinary Supply, NEVSCo, Midwest Veterinary Supply and Victor Medical Co.

Jurox earlier this summer opened its U.S. headquarters in Kansas City, Mo.

Edit Module
Edit ModuleShow Tags

Archive »Read More

4 Vets Accused of Drugging Racehorses

Prosecutors point to a long-running conspiracy at a Pennsylvania racetrack.

Texas Web Vet Loses Court Appeal

Dr. Ronald Hines provided email and telephone advice to pet owners without seeing the animal.

Water Additive Found to Reduce Dental Tartar

A study documented up to 25 percent less calculus on canine teeth with the use of StrixNB.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module